FERTILITY ANALYSIS IN MALE PATIENTS LONG SURVIVING BY HODGKIN'S LYMPHOMA

EHA Library, Francesco Gaudio, 324909

IMPACT OF COVID-19 ON AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MULTIPLE MYELOMA (MM) PATIENTS: A SINGLE-CENTRE, QUALITATIVE EVALUATION STUDY

EHA Library, Marquita Camilleri, 324910

OUTCOMES OF BRENTUXIMAB VEDOTIN AS ≥3 LINE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: PHYSICIAN’S AND PATIENT’S PERSPECTIVE

EHA Library, Tatyana Ionova, 324911

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA’S HUMANISTIC AND ECONOMIC BURDEN IN PATIENTS RECEIVING C5 INHIBITORS IN EUROPE

EHA Library, Jens Panse, 324912

DEVELOPING TREATMENT ATTRIBUTES FOR A PATIENT PREFERENCE SURVEY: A QUALITATIVE MULTINATIONAL STUDY IN MULTIPLE MYELOMA

EHA Library, Rosanne Janssens, 324913

HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH COLD AGGLUTININ DISEASE IN DENMARK

EHA Library, Emese Vágó, 324914

THE LIFETIME ECONOMIC BURDEN OF PYRUVATE KINASE DEFICIENCY IN THE UNITED STATES

EHA Library, Erin Zagadailov, 324915

'SHEFAA' AN ITP PATIENT ADVOCACY GROUP: AN EGYPTIAN SINGLE CENTER EXPERIENCE

EHA Library, Doaa El Demerdash , 324916

CHRONIC MYELOID LEUKEMIA ACCESS TO TYROSINE KINASE INHIBITORS AND POLYMERASE CHAIN REACTION TESTING IN CENTRAL AND EASTERN EUROPE AND WEST ASIA REGION: A PATIENT ADVOCACY PERSPECTIVE.

EHA Library, Jelena Čugurović, 324917

ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI MAY REDUCE RISK OF GRAFT FAILURE IN MATCHED SIBLING DONOR ALLOGENEIC HSCT IN ADULT SICKLE CELL PATIENTS

EHA Library, Elisabeth Dovern, 324918

GBT021601 IMPROVES THE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE IN A MURINE MODEL

EHA Library, Kobina Dufu, 324919

ELIGIBILITY FOR EMERGING THERAPIES IN SICKLE CELL DISEASE

EHA Library, Sona M Vora, 324920

HEMOPEXIN PROTECTS HUMAN ENDOTHELIAL CELLS FROM HEME-DRIVEN ACTIVATION AND DAMAGE IN VITRO

EHA Library, Jacqueline Adam, 324921

SILENT CEREBRAL INFARCTS IN A PEDIATRIC SICKLE CELL DISEASE NATURAL HISTORY COHORT: TOO MANY, TOO SOON?

EHA Library, Raffaella Colombatti, 324922

FT-4202 IMPROVES HEMATOLOGIC AND HEMOLYTIC PARAMETERS IN A PHASE 1 STUDY OF PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Clark Brown, 324923

CYTOKINE MAPPING IN PAEDIATRIC SICKLE CELL DISEASE: ARE DIFFERENT SIGNATURES ASSOCIATED WITH DIFFERENT PHENOTYPES?

EHA Library, Giulia Ceglie, 324924

DISTINCTIVE EFFECTS OF SYSTEMIC IRON RESTRICTION BY FERROPORTIN INHIBITION THROUGH VIT-2763 AND DIETARY IRON LIMITATION IN A SCD MODEL

EHA Library, Giada Ingoglia, 324925

SYSTEMATIC, POINT-OF-CARE NEWBORN SCREENING FOR SICKLE CELL DISEASE IN RURAL MALI, WEST AFRICA

EHA Library, Alan Anderson, 324926

REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR: A MULTICENTER, RETROSPECTIVE STUDY

EHA Library, Biree Andemariam, 324927

ASSOCIATION BETWEEN HOSPITALISED VASO-OCCLUSIVE CRISES AND MORTALITY IN SICKLE CELL DISEASE PATIENTS AGED 16 YEARS AND OLDER USING THE FRENCH NATIONAL HEALTH INSURANCE DATABASE (SNDS)

EHA Library, Jean-Benoît Arlet, 324928

BELGIAN SICKLE CELL DISEASE REGISTRY: DIVERSITY IN PRACTICE BUT LOW MORTALITY

EHA Library, Sarah Wambacq, 324929

REAL-WORLD EXPERIENCE OF VOXELOTOR FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE – A SINGLE-CENTER STUDY

EHA Library, Alan Anderson, 324930

PHARMACOKINETIC PROPERTIES OF A HUMAN PLASMA DERIVED HEMOPEXIN DRUG PRODUCT (CSL889) IN TOWNES HBSS-, WILD-TYPE MICE, RATS AND CYNOMOLGUS MONKEYS FOR THE TREATMENT OF ACUTE VOC IN SICKLE CELL DISEASE

EHA Library, Gerald Hoebarth, 324931

REAL-WORLD DATA FROM THE CRIZANLIZUMAB MANAGED ACCESS PROGRAM (MAP): BASELINE DISEASE BURDEN AND PRIOR TREATMENTS FOR PATIENTS WITH SICKLE CELL DISEASE (SCD) AND RECURRENT VASO-OCCLUSIVE CRISES (VOCS)

EHA Library, Ana Cristina Silva-Pinto, 324932

COMPLICATIONS OF SICKLE CELL DISEASE IN EAST LONDON NEWBORN COHORT PATIENTS OVER THE YEARS 2015-2018

EHA Library, Muriel Soriano, 324933

LOW SARS-COV-2 SEROPREVALENCE IN A COHORT OF SICKLE CELL DISEASE (SCD) PATIENTS: POSSIBLE EFFECTS OF EMPHASIS ON SOCIAL ISOLATION FOR A POPULATION INITIALLY CONSIDERED TO BE AT VERY HIGH RISK

EHA Library, Luiza Francisco Trafane, 324934

EVALUATION OF DIFFERENT ESTIMATED GLOMERULAR FILTRATION RATE AS RELIABLE MEASURES OF RENAL FUNCTION IN CHILDREN WITH SICKLE CELL DISEASE

EHA Library, Ilaria Liguoro, 324935

PRECLINICAL SAFETY AND TOXICITY ASSESSMENT OF A HUMAN PLASMA DERIVED HEMOPEXIN DRUG PRODUCT (CSL889) FOR THE TREATMENT OF ACUTE VOC IN SICKLE CELL DISEASE

EHA Library, Tanja Ruthsatz, 324936

ATTITUDES TOWARD THE MANAGEMENT OF SICKLE CELL DISEASE: RESULTS FROM TURKISH REGISTRY

EHA Library, Selma Ünal, 324937

ASSESSING TRANSITION OUTCOMES IN SICKLE CELL DISEASE (SCD) PRIOR TO IMPLEMENTATION OF A FORMAL TRANSITION PROGRAM

EHA Library, Sydney Sheppard, 324938

CHRONIC COMPLICATIONS OF SICKLE CELL DISEASE PATIENTS IN TURKEY

EHA Library, Selma Ünal, 324939

A LONGITUDINAL OBSERVATIONAL STUDY TO EVALUATE THE PSYCHOMETRIC PROPERTIES OF A DAILY DIARY FOR ADOLESCENTS AND ADULTS WITH SICKLE CELL DISEASE

EHA Library, Clark Brown, 324940

ECONOMIC BURDEN OF SICKLE CELL DISEASE IN THE MIDDLE EAST

EHA Library, Hatoon Ezzat, 324941

THE VALUE OF THE YEARS CLINICAL DECISION ALGORITHM TO RULE OUT PULMONARY EMBOLISM IN PATIENTS WITH SICKLE CELL DISEASE: A RETROSPECTIVE EVALUATION.

EHA Library, Aafke Gaartman, 324942

FACTORS ASSOCIATED WITH HOSPITAL ADMISSION DUE TO VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE: RETROSPECTIVE ANALYSIS OF 3-YEAR OBSERVATIONAL STUDY DATA

EHA Library, Matthew Heeney, 324943

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY/RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA AFTER ALLOGENEIC CD7-CART CELL THERAPY

EHA Library, Zhihui Li, 324944

PHASE 2 STUDY OF MGTA-145 + PLERIXAFOR FOR RAPID AND RELIABLE HEMATOPOIETIC STEM CELL (HSC) MOBILIZATION FOR AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA

EHA Library, Surbhi Sidana, 324945

FIRST-IN-HUMAN CLINICAL TRIAL OF BCMA-CD19 COMPOUND CAR IN THE REDUCTION OF DONOR-SPECIFIC ANTIBODY IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Fang Liu, 324946

MINIMAL RESIDUAL DISEASE MONITORING AND PREEMPTIVE IMMUNOTHERAPIES FOR FREQUENT 11Q23 REARRANGED ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jing Liu, 324947

SURVIVAL TRENDS OF ADULT PATIENTS WITH RELAPSED PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OVER 20 YEARS: AN ALWP-EBMT ANALYSIS

EHA Library, Ali Bazarbachi, 324948

COMPARISON OF OUTCOMES OF SINGLE CORD BLOOD TRANSPLANTATION AND HLA 1-3 ANTIGEN-MISMATCHED RELATED STEM CELL TRANSPLANTATION USING LOW-DOSE ANTITHYMOCYTE GLOBULIN FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, Fumiya Wada, 324949

OUTCOMES FOLLOWING UNMANIPULATED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AMONG 111 MIXED-PHENOTYPE ACUTE LEUKEMIA PATIENTS AT A SINGLE CENTER

EHA Library, Yan-Li Zhao, 324950

CURRENT ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN MANTLE CELL LYMPHOMA (MCL) IN THE ERA OF NEW IMMUNOTHERAPEUTIC AND TARGETED THERAPIES. THE GETH/GELTAMO EXPERIENCE.

EHA Library, Antonio Gutiérrez, 324951

DYNAMIC ASSESSMENT OF PERIPHERAL PERFUSION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION SURVIVORS

EHA Library, Eleni Gavriilaki, 324952

DAY 0 EASIX SCORE MIGHT PREDICT OVERALL SURVIVAL AND TRANSPLANT RELATED MORTALITY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE.

EHA Library, Elisabetta Metafuni, 324953

EARLY-ONSET CYTOKINE RELEASE SYNDROME FOLLOWING ALLOGENEIC HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION MIGHT DECREASE OVERALL SURVIVAL

EHA Library, Alberto Hernandez-Sanchez, 324954

TRIAL OF AB-205 (E-CEL® CELLS) IN ADULTS WITH SYSTEMIC LYMPHOMA UNDERGOING HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HDT-AHCT)RESULTS OF AB-205-001 BY AGE SUBGROUP

EHA Library, Mehrdad Abedi, 324955

DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND MORTALITY OF ADULT HEMATOLOGICAL CANCER PATIENTS WITH VENO-OCCLUSIVE DISEASE IN ENGLAND, 2010 TO 2020

EHA Library, Indraraj Umesh Doobaree, 324956

PHASE II CLINICAL TRIAL (EMN-ALLORIC 2010) OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR HIGH RISK (HR) MULTIPLE MYELOMA (MM) FOLLOWED BY MAINTENANCE WITH BORTEZOMIB AND LENALIDOMIDE. UPDATED ANALYSIS.

EHA Library, Marta Reinoso Segura, 324957

LATE-ONSET VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED PATIENTS FROM THE EBMT PASS REGISTRY STUDY

EHA Library, James Angus, 324958

OPTIMOB STUDY: INTERIM ANALYSIS OF THIS NON-INTERVENTIONAL TRIAL IN GERMANY TO EVALUATE THE MOBILIZATION AND COLLECTION OF HEMATOPOIETIC STEM CELLS IN POOR MOBILIZERS

EHA Library, Christian Kunz, 324959

CO-REACTIVATION OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS WAS ASSOCIATED WITH POOR PROGNOSIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Jing-Rui Zhou, 324960

IMPACT OF IMMUNE STATUS ON HOSPITAL READMISSION AFTER ALLO-HSCT

EHA Library, Irina Galtseva, 324961

ASSOCIATION OF TRAVEL TIME TO TRANSPLANT CENTER AND POST-TRANSPLANT CARE MODEL WITH OUTCOME PARAMETERS AFTER ALLOGENEIC TRANSPLANTATION

EHA Library, Raffaele Peter, 324962

THE ADDITION OF ATG TO NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND CYCLOPHOSPHAMIDE REDUCES GVHD AT THE EXPENSE OF HIGHER RELAPSE RATES AND POORER OVERALL SURVIVAL.

EHA Library, Mayani Rawicki, 324963

EVALUATION OF SOLUBL HLA-G AND CYTOKINE LEVELS IN CHILDREN WITH ACUTE LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Zéhre Kaya, 324964

SUBMYELOABLATIVE TBI-BASED CONDITIONING AND ALLOGENEIC HEMATOPOETIC CELL TRANSPLANTATION IN HIGH-RISK MYELOMA WITH EARLY PROGRESSION POST AUTOLOGOUS TRANSPLANTATION

EHA Library, Elias K. Mai, 324965

G-CSF-PRIMED PERIPHERAL BLOOD STEM CELL HAPLOIDENTICAL TRANSPLANTATION COULD ACHIEVE SATISFACTORY CLINICAL OUTCOMES FOR ACUTE LEUKEMIA PATIENTS IN THE FIRST COMPLETE REMISSION: A REGISTERED STUDY

EHA Library, Yanru Ma, 324966

MAINTENANCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANT FOR ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Oren Pasvolsky, 324967

OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AML PATIENTS WITH 11P15/NUP98 REARRANGEMENT

EHA Library, Shu Yan, 324968

EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION(HSCT)IN SEVERE CONGENITAL NEUTROPENIA

EHA Library, Min Xiong, 324969

OUTPATIENT PROGRAM BASED ON TELEMEDICINE IS A GOOD OPTION TO MANAGE PRE-ENGRAFTMENT PHASE IN MYELOMA MULTIPLE PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Pedro Gonzalez-Sierra, 324970

INCIDENCE OF EARLY TOXICITIES AND MORTALITY AFTER 4 TYPES OF CONDITIONING REGIMENS FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMAS: A RETROSPECTIVE ANALYSIS.

EHA Library, Jhonny Manuel Carranza Jara, 324971

DEVELOPMENT AND VALIDATION OF A RISK SCORE SYSTEM FOR SKIN AND SOFT TISSUE INFECTIONS IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

EHA Library, Shan Chong, 324972

SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN SALAMANCA, SPAIN.

EHA Library, Felipe Peña Muñoz, 324973

THE IMPACT OF MEASURABLE RESIDUAL DISEASE POSITIVITY BEFORE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH PH(-) ACUTE LYMPHOBLASTIC LEUKEMIA : A SINGLE CENTER EXPERIENCE

EHA Library, Apostolia Papalexandri, 324974

PERIPHERAL BLOOD STEM CELL APHERESIS IN LOW-WEIGHT HEALTHY DONORS: A SINGLE CENTRE EXPERIENCE

EHA Library, Malek Benakli, 324975

IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Eleni Gavriilaki, 324976

A MODIFIED BUSULFAN/CYCLOPHOSPHAMIDE CONDITIONING REGIMEN INCORPORATING CLADRIBINE FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Yuanyuan Shi, 324977

INCIDENCE OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION IN ENGLAND BASED ON HEALTHCARE RESOURCE GROUP CODES AND HOSPITAL EPISODE STATISTICS© DATA

EHA Library, James Angus, 324978

THE EFFECT OF MYELOMA INDUCTION THERAPY TYPE AND DURATION ON PERIPHERAL BLOOD STEM CELL HARVEST FOR AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Charlotte Pawlyn, 324979

ADVERSE IMPACT OF PRE-TRANSPLANT MINIMAL RESIDUAL DISEASE ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA PATIENTS.

EHA Library, Zoya Konova, 324980

RELATIONSHIP OF HLA ALLELES AND THE RISK OF CYTOMEGALOVIRUS (CMV) REACTIVATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)

EHA Library, Shruti Prem Sudha, 324981

SURVIVAL AFTER SEQUENTIAL FLAMSA-BU CONDITIONING REGIMEN IS HIGHLY DEPENDENT ON PRE-HSCT MRD STATUS IN HIGH-RISK MYELOID NEOPLASM

EHA Library, Grégoire Le Meur, 324982

LETERMOVIR FOR CMV PROPHYLAXIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION - CLINICAL 'REAL WORLD' EXPERIENCE

EHA Library, Lana Desnica, 324983

THE PRELIMINARY RESULTS OF EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL.

EHA Library, Aleksei Koviazin, 324984

KIR2DL2/L3 SINGLE POSITIVE/NKG2C+ NK CELLS SIGNIFICANTLY EXPAND IN NKG2C+ NK CELLS DURING EDUCATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Wei Zuo, 324985

DOWN-REGULATION OF HLA EXPRESSION IN ACUTE LEUKEMIA PATIENTS RELAPSED POST TRANSPLANTATION CORRELATED WITH MRD DURATION

EHA Library, Hui Wang, 324986

DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Beatrice De Marco, 324987

FEASIBILITY OF ALLOGENEIC STEM-CELL TRANSPLANTATION WITH CONDITIONING REGIMEN OF 5-DAY DECITABINE IN MDS AND MDS/MPN：A MULTICENTER PROSPECTIVE COHORT STUDY IN CHINA

EHA Library, Yigeng Cao, 324988

DONOR-DERIVED ACTIVATED NK CELLS IN MANAGEMENT OF RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA

EHA Library, Zhihui Li, 324989

RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Maiia Soloveva, 324990

POST-TRANSPLANTATION FLUDARABINE AND CYCLOPHOSPHAMIDE SELECTED AND PROMOTED UNRELATED UCB IMPLANTATION IN COMBINED TRANSPLANTION OF HALPOID AND UCB STEM CELLS FOR TREATMENT OF PEDIATRIC LEUKEMIA

EHA Library, Xiaoqin Feng, 324991

RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL): WHO SHOULD RECEIVE CONSOLIDATION TREATMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)? EXPERIENCE OUTSIDE CLINICAL TRIALS.

EHA Library, Dimitrios Galopoulos, 324992

AREA UNDER THE CURVE BASED MYCOPHENOLATE MOFETIL DOSAGE REDUCED THE INCIDENCE OF GVHD AFTER ALLOGENIC HSCT IN PEDIATRIC PATIENTS: ONE FACILITY'S EIGHT-YEAR EXPERIENCE

EHA Library, Antonio Grasso, 324993

EBMT, RPAM AND EASIX SCORES – IS THERE A BETTER PREDICTOR OF SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA?

EHA Library, Carolina Afonso, 324994

PREVALENCE OF PURE RED CELL APLASIA AFTER HEMATOPOIETIC TRANSPLANTATION USING MAJOR ABO-INCOMPATIBLE UNMANIPULATED PERIPHERAL BLOOD STEM CELLS

EHA Library, Yi Luo, 324995

EXCELLENT COMPARABLE OUTCOMES OF HAPLO-HSCT IN HIGH RISK MYELOID MALIGNANCIES USING MYELOABLATIVE OR REDUCED INTENSITY CONDITIONING WITH LOW RISK OF CGVHD IN RECIPIENTS OF PERIPHERAL BLOOD STEM CELL

EHA Library, Daniele Avenoso, 324996

CLINICAL EXPERIENCE OF VENETOCLAX THERAPY AS A BRIDGE TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Tingting Yang, 324997

INCIDENCE, ETIOLOGY AND PROGNOSTIC IMPACT OF ATYPICAL ELECTROPHORETIC PROFILES IN PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hedhli Kaies, 324998

GOOD OUTCOME OF HIGH-RISK MYELOFIBROSIS IN ELDERLY RECIPIENTS AFTER FULL INTENSITY T-DEPLETE CONDITIONING WITH FLUDARABINE, BUSULFAN, WITH SINGLE AGENT CICLOSPORIN AS GVHD PROPHYLAXIS.

EHA Library, Daniele Avenoso, 324999

THE RELATIONSHIP BETWEEN THE CONCENTRATION OF VITAMIN A, C AND E, CYTOKINES AND THE OCCURRENCE AND SEVERITY OF MUCOSITIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES UNDERGOING AHSCT

EHA Library, Agnieszka Szymczyk, 325000

PROGNOSTIC FACTORS AND OUTCOME OF CYTOMEGALOVIRUS INFECTION IN POST-ALLOGENEIC STEM CELL RECIPIENTS. FIVE YEARS RETROSPECTIVE STUDY.

EHA Library, José Quintela, 325001

THE IMPACT OF HEMATOPOIETIC STEM CELLS QUANTITY AND QUALITY ON HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS OR ALLOGENIC GRAFT: A TWO YEARS MULTICENTRIC RETROSPECTIVE STUDY

EHA Library, Caroline De Oliveira, 325002

THE DURATION OF ANTIBIOTICS WITH DIFFERENT SPECTRUMS ADMINISTERED DURING ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION CAN PREDICT GVHD.

EHA Library, Meltem Kurt Yüksel, 325003

EXCELLENT ENGRAFTMENT AND LOW RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS AFTER CONDITIONING WITH FLUDARABINE, TREOSULFAN AND ATG: A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Catharina Hazenberg, 325004

THE IMPACT OF PRETRANSPLANT BODY MASS INDEX ON OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Sabrine Mekni, 325005

IMPACT OF DARATUMUMAB (DARA) ADMINISTRATION DURING TRANSPLANT- ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) INDUCTION ON STEM CELL (SC) MOBILIZATION COUNT AND POST-TRANSPLANT ENGRAFTMENT.

EHA Library, Edvan Crusoe, 325006

ALLOGENEIC STEM CELL TRANSPLANTATION OF PATIENTS WITH MYELOFIBROSIS AT UNIVERSITY HOSPITAL CENTRE ZAGREB FROM 2010 TO 2020

EHA Library, Radovan Vrhovac, 325007

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH TBI-BASED REDUCED INTENSITY CONDITIONING FOLLOWED BY POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR RELAPSED/REFRACTORY LYMPHOMA PATIENTS.

EHA Library, Mario Griselli, 325008